INDIVIDUALIZATION OF LEVODOPA THERAPY

被引：7

作者：

BIANCHINE, JR

SUNYAPRIDAKUL, L

机构：

[1] TEXAS TECH UNIV, SCH MED, DEPT PHARMACOL & EXPTL THERAPEUTICS, LUBBOCK, TX 79409 USA

[2] TARBOR PARKINSONS DIS RES INST, LUBBOCK, TX USA

来源：

关键词：

D O I：

10.1016/S0025-7125(16)32103-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1071 / 1081

页数：11

共 50 条

[1]

BARBEAU A, 1972, CAN MED ASSOC J, V106, P1169

[2]

BIANCHINE JR, 1973, ADV NEUROL, V2, P101

[3]

BIRKETSMITH E, 1973, LANCET, V1, P431

[4] ADJUVANTS TO L-DOPA FOR PARKINSONISM [J].

BRAHAM, J .

[5] ANTIPARKINSONIAN DRUGS PHARMACOLOGICAL AND THERAPEUTIC ASPECTS [J].

CALNE, DB ;

REID, JL .

CAMMANI, F ;

MASSARA, F .

[7]

CAWEIN MJ, 1970, NEW ENGL J MED, V283, P659

[8]

CHAKMAKJIAN ZH, 1973, PEDIATR RES, V7, P71

[9]

CHASE TN, 1972, NEUROLOGY, V22, P479, DOI 10.1212/WNL.22.5.479

[10] PRELIMINARY REMARKS ON L-DOPA THERAPY OF DYSTONIA [J].

COLEMAN, M .